AI assistant
BeyondSpring Inc. — Director's Dealing 2024
Dec 31, 2024
34404_dirs_2024-12-31_f035dc08-b18f-497c-b77d-9d2ccd9cad8e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: BeyondSpring Inc. (BYSI)
CIK: 0001677940
Period of Report: 2024-12-31
Reporting Person: Huang Lan (N/A)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Ordinary Shares | 2 | Indirect |
| Ordinary Shares | 1 | Indirect |
| Ordinary Shares | 1 | Indirect |
| Ordinary Shares | 323702 | Indirect |
| Ordinary Shares | 413636 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Options (right to buy) | $11.03 | 2030-08-01 | Ordinary Shares (460000) | Direct | |
| Stock Options (right to buy) | $4.69 | 2032-01-11 | Ordinary Shares (90343) | Direct | |
| Stock Options (right to buy) | $0.9835 | 2033-05-08 | Ordinary Shares (400000) | Direct | |
| Stock Options (right to buy) | $3.168 | 2034-03-19 | Ordinary Shares (33663) | Direct |
Footnotes
F1: The reporting person is the sole owner of Ever Regal Group Limited.
F2: The reporting person's spouse is the sole owner of Fairy Eagle Investments Limited.
F3: The reporting person's spouse is the sole owner of Rosy Time Holdings Limited.
F4: Reflects shares held by the Lan Huang 2022 Grantor Retained Annuity Trust (the "2022 GRAT") for the benefit of Dr. Lan Huang's children. Dr. Lan Huang is trustee of the 2022 GRAT.
F5: Reflects shares held by the 2024 SPIRIT GRAT for the benefit of Dr. Lan Huang's children. Dr. Lan Huang is trustee of the 2024 SPIRIT GRAT.
F6: Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. 388,000 of the stock options are fully vested and exercisable. 72,000 of the stock options will vest on December 31, 2024.
F7: Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. All 90,343 stock options are fully vested and exercisable.
F8: Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. 133,333 of the stock options are fully vested and exercisable. 133,333 of the stock options will vest on May 8, 2025, and 133,334 of the stock options will vest on May 8, 2026.
F9: Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. 11,221 of the stock options are fully vested and exercisable. 11,221 of the stock options will vest on December 31, 2024, and 11,221 of the stock options will vest on June 30, 2025.